Health Policy Archive — Page 3 of 7
-
January 19, 2023
Emerging Infections Program lands national award for COVID response
Vanderbilt's Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry. -
November 3, 2022
Researcher’s decade of analyzing the price of drugs leads to big reforms
Vanderbilt's Stacie Dusetzina, PhD, and several colleagues were able to reflect recently on the South Lawn of the White House about how their contributions through research and data informed the provisions in the Inflation Reduction Act that will save older Americans on Medicare tens of thousands of dollars in out-of-pocket costs each year. -
July 14, 2022
Hospital readmissions tied to supply of nearby care options: study
Vanderbilt research finds that hospitals' 30-day readmission rates were lower if they had a larger supply of primary care physicians, nursing homes or palliative care services nearby. -
June 28, 2022
Insurance claims for gender-affirming therapies have increased, but filling prescriptions without insurance may be more affordable, new study finds
Vanderbilt researchers found that both gender dysphoria diagnoses and use of gender therapies have increased substantially between 2013 and 2019. -
June 9, 2022
Filling multiple opioid prescriptions after childbirth associated with maternal death risk
In a new study led by Vanderbilt University Medical Center researchers, women who filled two or more prescriptions for opioids after childbirth faced a 46% greater risk of death than women who did not. -
May 10, 2022
New study illustrates how much it would cost for cancer drugs covered under Medicare Part D
A new study by Vanderbilt researchers highlights how some older Americans diagnosed with cancer can face unlimited out-of-pocket spending for prescription drugs under the current structure of the Medicare Part D benefit. -
April 4, 2022
Medicare beneficiaries without low-income subsidies were less likely to fill important prescriptions, new study finds
Vanderbilt research shows that Medicare Part D beneficiaries who did not receive federal subsidies to lower their out-of-pocket costs were nearly twice as likely as others to not fill prescriptions for serious health conditions like cancer or hepatitis C treatment.